In line with the in vitro findings, napabucasin down-regulated Nanog, SOX2, Klf4 and Oct4 in the tumor cells (Figure 6E), and also decreased the proportion of Ki67+ tumor cells (Figures 6F,G). This evidence concerns the gene SOX2 and neoplasm.